Mal-β-Ala-PEG(4)-Val-Cit-PAB
CAS: 1949793-41-2
Ref. 3D-ZCD79341
| 1g | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
Mal-β-Ala-PEG(4)-Val-Cit-PAB
Description:
Mal-beta-Ala-PEG(4)-Val-Cit-PAB is a PEG linked peptide that belongs to the family of PEG products. It is a pegylated peptide that has been modified with polyethylene glycol (PEG) to enhance its stability and prolong its half-life in the body. This modification also helps to protect the peptide from degradation and improve its bioavailability. Mal-beta-Ala-PEG(4)-Val-Cit-PAB can be used in various applications, including drug delivery systems, diagnostics, and therapeutics. Its unique structure and properties make it an ideal choice for researchers and scientists working in the field of peptide-based therapies.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
777.9 g/mol
Formula:
C36H55N7O12
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
